Pharmacoepidemiology and Drug Safety

Cover image for Vol. 26 Issue 1

Early View (Online Version of Record published before inclusion in an issue)

Edited By: B.L. Strom, USA; S. Hennessy, USA; H. G. M. Leufkens, The Netherlands; B.J. Park, Korea

Impact Factor: 2.908

ISI Journal Citation Reports © Ranking: 2015: 82/255 (Pharmacology & Pharmacy)

Online ISSN: 1099-1557


  1. 1 - 42
  1. Brief Reports

    1. Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment

      Suzanne Nielsen, Natasa Gisev, Raimondo Bruno, Wayne Hall, Milton Cohen, Briony Larance, Gabrielle Campbell, Marian Shanahan, Fiona Blyth, Nicholas Lintzeris, Sallie Pearson, Richard Mattick and Louisa Degenhardt

      Version of Record online: 19 JAN 2017 | DOI: 10.1002/pds.4168

  2. Original Reports

    1. Exposure to reactive intermediate-inducing drugs during pregnancy and the incident use of psychotropic medications among children

      Yen-Hao Tran, Henk Groen, Jorieke E.H. Bergman, Eelko Hak and Bob Wilffert

      Version of Record online: 18 JAN 2017 | DOI: 10.1002/pds.4161

    2. Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry study

      Rolf Gedeborg, Bodil Svennblad, Lennart Holm, Hans Sjögren, Carola Bardage, Mark Personne, Gunilla Sjöberg, Nils Feltelius and Björn Zethelius

      Version of Record online: 13 JAN 2017 | DOI: 10.1002/pds.4166

    3. Propacetamol poses a potential harm of adverse hypotension in male and older patients

      Hyun-Young Lee, Ga-Young Ban, Chang-Gyu Jeong, Ji-Ho Lee, Seung-Hee Park, Sang-Hee Kim, Young-Hee Lee and Young-Min Ye

      Version of Record online: 13 JAN 2017 | DOI: 10.1002/pds.4159

    4. Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case–control study

      Chor-Wing Sing, Ian C. K. Wong, Bernard M. Y. Cheung, Johnny C. Y. Chan, Jody K. P. Chu and Ching-Lung Cheung

      Version of Record online: 13 JAN 2017 | DOI: 10.1002/pds.4156

    5. Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records

      Carla A. Green, Nancy A. Perrin, Shannon L. Janoff, Cynthia I. Campbell, Howard D. Chilcoat and Paul M. Coplan

      Version of Record online: 10 JAN 2017 | DOI: 10.1002/pds.4157

    6. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden

      Lennart Holm, Elisabet Ekman and Kerstin Jorsäter Blomgren

      Version of Record online: 10 JAN 2017 | DOI: 10.1002/pds.4155

    7. Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome

      Chen-Yu Wang, Zhen-Fang Lin, Chii-Ming Lee, Yi-Wen Tsai, Ting-Ying Huang, Li-Jiuan Shen and Fei-Yuan Hsiao

      Version of Record online: 9 JAN 2017 | DOI: 10.1002/pds.4147

  3. Commentaries

    1. Pioglitazone and bladder cancer: FDA's assessment

      Christian Hampp and Jennifer Pippins

      Version of Record online: 9 JAN 2017 | DOI: 10.1002/pds.4154

  4. Original Reports

    1. Identifying birth defects in automated data sources in the Vaccine Safety Datalink

      Elyse Olshen Kharbanda, Gabriela Vazquez-Benitez, Paul A. Romitti, Allison L. Naleway, T. Craig Cheetham, Heather S. Lipkind, Shanthi Sivanandam, Nicola P. Klein, Grace M. Lee, Michael L. Jackson, Simon J. Hambidge, Avalow Olsen, Natalie McCarthy, Frank DeStefano and James D. Nordin

      Version of Record online: 4 JAN 2017 | DOI: 10.1002/pds.4153

    2. Natural language processing to ascertain two key variables from operative reports in ophthalmology

      Liyan Liu, Neal H. Shorstein, Laura B. Amsden and Lisa J. Herrinton

      Version of Record online: 3 JAN 2017 | DOI: 10.1002/pds.4149

    3. Antiepileptic drugs and risk of suicide attempts: a case–control study exploring the impact of underlying medical conditions

      Lamiae Grimaldi-Bensouda, Clementine Nordon, Michel Rossignol, Vincent Jardon, Virginie Boss, Frédérique Warembourg, Robert Reynolds, Xavier Kurz, Frédéric Rouillon, Lucien Abenhaim and for the PROTECT-WP6 study group

      Version of Record online: 3 JAN 2017 | DOI: 10.1002/pds.4160

    4. The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights

      Jeffrey R. Curtis, Lang Chen, Jeffrey D. Greenberg, Leslie Harrold, Meredith L. Kilgore, Joel M. Kremer, Daniel H. Solomon and Huifeng Yun

      Version of Record online: 28 DEC 2016 | DOI: 10.1002/pds.4126

    5. A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection

      Kate Gelperin, Hoda Hammad, Kira Leishear, Steven T. Bird, Lockwood Taylor, Christian Hampp and Leyla Sahin

      Version of Record online: 27 DEC 2016 | DOI: 10.1002/pds.4150

    6. Drug availability adjustments in population-based studies of prescription opioid abuse

      Alex Secora, James Phillip Trinidad, Rongmei Zhang, Rajdeep Gill and Gerald Dal Pan

      Version of Record online: 21 DEC 2016 | DOI: 10.1002/pds.4139

    7. The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortality

      Catherine B. Johannes, Lisa J. McQuay, Kirk D. Midkiff, Brian Calingaert, Elizabeth B. Andrews, Patricia Tennis, Jeffrey S. Brown, Carlos A. Camargo, Jr., Rachael L. DiSantostefano, Kenneth J. Rothman, Til Stürmer, Stephan Lanes and Kourtney J. Davis

      Version of Record online: 21 DEC 2016 | DOI: 10.1002/pds.4151

    8. Patient-related characteristics associated with non-persistence with statin therapy in elderly patients following an ischemic stroke

      Martin Wawruch, Dusan Zatko, Gejza Wimmer Jr, Jan Luha, Vasil Hricak Jr, Jan Murin, Peter Kukumberg, Tomas Tesar, Adam Hloska and Rashmi Shah

      Version of Record online: 9 DEC 2016 | DOI: 10.1002/pds.4148

    9. Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding

      Antonio González-Pérez, María Eugenia Sáez, Saga Johansson, Péter Nagy and Luis A. García Rodríguez

      Version of Record online: 6 DEC 2016 | DOI: 10.1002/pds.4140

    10. Comparison of pharmacy-based and diagnosis-based comorbidity measures from medical administrative data

      Sébastien Cortaredona, Elodie Pambrun, Hélène Verdoux and Pierre Verger

      Version of Record online: 2 DEC 2016 | DOI: 10.1002/pds.4146

  5. Brief Reports

    1. You have full text access to this OnlineOpen article
      New use of prescription drugs prior to a cancer diagnosis

      Anton Pottegård and Jesper Hallas

      Version of Record online: 27 NOV 2016 | DOI: 10.1002/pds.4145

  6. Original Reports

    1. Decision making in drug safety—a literature review of criteria used to prioritize newly detected safety issues

      Alexandra C. Pacurariu, Preciosa M. Coloma, Liana Gross-Martirosyan, Miriam C. Sturkenboom and Sabine M. Straus

      Version of Record online: 23 NOV 2016 | DOI: 10.1002/pds.4128

    2. Validation of Stevens–Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink

      Noel Frey, Andreas Bircher, Michael Bodmer, Susan S. Jick, Christoph R. Meier and Julia Spoendlin

      Version of Record online: 20 NOV 2016 | DOI: 10.1002/pds.4124

    3. Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011

      Carsten Schröder, Michael Dörks, Bianca Kollhorst, Tilo Blenk, Ralf W. Dittmann, Edeltraut Garbe and Oliver Riedel

      Version of Record online: 20 NOV 2016 | DOI: 10.1002/pds.4138

    4. A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example

      Raymond A. Harvey, Jennifer D. Hayden, Pravin S. Kamble, Jonathan R. Bouchard and Joanna C. Huang

      Version of Record online: 13 NOV 2016 | DOI: 10.1002/pds.4121

  7. Brief Reports

    1. Are non-allergic drug reactions commonly documented as medication “allergies”? A national cohort of Veterans' admissions from 2000 to 2014

      Kevin W. McConeghy, Aisling R. Caffrey, Haley J. Morrill, Amal N. Trivedi and Kerry L. LaPlante

      Version of Record online: 13 NOV 2016 | DOI: 10.1002/pds.4134

  8. Original Reports

    1. Assessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data

      Stefania Salvatore, Jo Røislien, Jose A. Baz-Lomba and Jørgen G. Bramness

      Version of Record online: 11 NOV 2016 | DOI: 10.1002/pds.4127

    2. Improving medical record retrieval for validation studies in Medicare data

      Nicole C. Wright, Elizabeth S. Delzell, Wilson K. Smith, Fei Xue, Tarun Auroa and Jeffrey R. Curtis

      Version of Record online: 7 NOV 2016 | DOI: 10.1002/pds.4131

    3. Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study

      Anne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, Fabienne Bazin, Hélène Verdoux, Marie Tournier, Bernard Bégaud and Antoine Pariente

      Version of Record online: 3 NOV 2016 | DOI: 10.1002/pds.4123

    4. You have full text access to this OnlineOpen article
      Monitoring safety in a phase III real-world effectiveness trial: use of novel methodology in the Salford Lung Study

      Sue Collier, Catherine Harvey, Jill Brewster, Nawar Diar Bakerly, Hanaa F. Elkhenini, Roxana Stanciu, Claire Williams, Jacqui Brereton, John P. New, John McCrae, Sheila McCorkindale and David Leather

      Version of Record online: 1 NOV 2016 | DOI: 10.1002/pds.4118

    5. Drug use among complete responders, partial responders and non-responders in a longitudinal survey of nonagenarians: analysis of prescription register data

      Jonas W. Wastesson, Lotte Rasmussen, Anna Oksuzyan, Jesper Hallas, Kaare Christensen and Anton Pottegård

      Version of Record online: 28 OCT 2016 | DOI: 10.1002/pds.4120

    6. Differences between the United States and Japan in labels of oncological drugs

      Karina Jayaputra and Shunsuke Ono

      Version of Record online: 26 SEP 2016 | DOI: 10.1002/pds.4111

    7. You have full text access to this OnlineOpen article
    8. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales

      Preeti Datta-Nemdharry, Andrew Thomson, Julie Beynon and Katherine Donegan

      Version of Record online: 19 SEP 2016 | DOI: 10.1002/pds.4092

    9. Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores

      Samy Suissa, Erica E. M. Moodie and Sophie Dell'Aniello

      Version of Record online: 9 SEP 2016 | DOI: 10.1002/pds.4107

    10. The appropriateness and persistence of testosterone replacement therapy in Ontario

      Diana Martins, Zhan Yao, Mina Tadrous, Baiju R. Shah, David N. Juurlink, Muhammad M. Mamdani, Tara Gomes and On behalf of the Ontario Drug Policy Research Network

      Version of Record online: 16 AUG 2016 | DOI: 10.1002/pds.4083

    11. Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis

      Katsiaryna Bykov, Kazuki Yoshida, Marc G. Weisskopf and Joshua J. Gagne

      Version of Record online: 16 AUG 2016 | DOI: 10.1002/pds.4079

    12. You have full text access to this OnlineOpen article
      Development of an adverse events reporting form for Korean folk medicine

      Jeong Hwan Park, Sun-Mi Choi, Sujeong Moon, Sungha Kim, Boyoung Kim, Min-Kyeoung Kim and Sanghun Lee

      Version of Record online: 8 AUG 2016 | DOI: 10.1002/pds.4077

  9. Abstracts


  1. 1 - 42